An interventional study of PAULA interactive patient education app and General control video in Cataract and Informed Consent, sponsored by Johannes Kepler University of Linz. Completed at 1 site in Austria. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Johannes Kepler University of Linz · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Cataract by Johannes Kepler University of Linz — 3 open to participants now, 3 under way, none of them phase 3. Cataract · Johannes Kepler University of Linz.
Among the 11 studies in Cataract by Johannes Kepler University of Linz, this one is one of 2 that started in 2026, is one of 2 with no phase, and was the 11th registered.
1,632 studies on the registry are indexed under Cataract; 235 are open to participants now.
Browse Cataract studies →3 of the 11 studies in Cataract by Johannes Kepler University of Linz are open now, in 1 country. Recruiting first, the newest first:
Johannes Kepler University of Linz · Sites in Austria
Ages 21+
Johannes Kepler University of Linz · Sites in Austria
Ages 21–110
Johannes Kepler University of Linz · Sites in Austria
Ages 21+
By country, each count listing its studies:
Of the 142 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 16 take healthy volunteers.
This study: 21 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 2 started in 2026.
This study's enrollment of 90 is above the median of 79 across 1,094 interventional studies indexed under Cataract.
Median enrollment 53 across the 2 interventional studies, 110 across the 9 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Johannes Kepler University of Linz is the lead sponsor of 34 studies on the registry; 12 are open to participants now.
2 of the studies in Cataract by Johannes Kepler University of Linz that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07294716Johannes Kepler University of LinzImproving Visual Quality in Patients With Irregular Corneas Using Asymmetrical Toric Intraocular Lenses | 2027-01 |
| NCT07202767Johannes Kepler University of LinzIntraocular Lens Calculation Using Artificial Intelligence | 2027-07-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies in Cataract by Johannes Kepler University of Linz, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial investigated whether an interactive multimedia patient education app (PAULA), used before the informed consent discussion with a physician, improves patients' knowledge about cataract surgery compared with a general video without medical content.
Informed consent before cataract surgery is usually provided verbally and in writing. Patients often retain only part of this information, and the content and duration of consent discussions vary between physicians. PAULA (Patient Education and Learning Application) is an interactive, multimedia tablet application developed for preoperative education of cataract patients. It explains the indication for surgery, the surgical procedure, possible risks and complications, and the postoperative course using animations, audio, text and interactive elements. The app provides generic, standardized information identical in content to the standard consent discussion and the paper consent form; it does not process patient-specific data and has no diagnostic or therapeutic purpose. It is intended to complement, not replace, the physician's consent discussion. This prospective, randomized, controlled, single-center study was conducted at the Department of Ophthalmology and Optometry, Kepler University Hospital Linz, Austria. Adults scheduled for cataract surgery were included after confirmation of eligibility and written informed consent and were allocated by computer-generated randomization in a 2:1 ratio to the intervention group (PAULA app on a tablet) or the control group (general video without cataract-specific content). Subsequently, all participants received the standard face-to-face informed consent discussion with a physician masked to group allocation, and the duration of this discussion was recorded. Participants then completed a 20-item single-choice knowledge questionnaire on cataract surgery, the Decisional Conflict Scale (DCS) and the German version of the Catquest-9SF; participants in the intervention group additionally completed the System Usability Scale (SUS). Enrollment and all data collection took place during a single visit of about one hour on the same day; no follow-up visit was required. Cataract surgery and all medical care were identical in both groups. The study was approved by the Ethics Committee of the Johannes Kepler University Linz (EK 1495/2025).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants used the interactive multimedia patient education app PAULA on a tablet before the standard face-to-face informed consent discussion with a physician.
Behavioral: PAULA interactive patient education app
Participants watched a general video without cataract-specific medical content before the standard face-to-face informed consent discussion with a physician.
Behavioral: General control video
Interactive tablet application (PAULA, Patient Education and Learning Application) explaining the indication, procedure, risks, complications and postoperative course of cataract surgery using animations, audio, text and interactive elements. Content is generic and identical to the standard consent discussion and paper consent form; used once before the physician's consent discussion.
General video without specific medical content regarding cataract or cataract surgery, shown once before the physician's consent discussion.
Objective Knowledge About Cataract Surgery
Score on a 20-item single-choice questionnaire assessing knowledge about cataract, cataract surgery, risks and postoperative course. Score range 0-20 (number of correct answers); higher scores indicate better knowledge.
Time frame: immediately after the preoperative informed consent discussion
Duration of the Physician's Informed Consent Discussion
Duration of the face-to-face informed consent discussion between physician and participant, measured in minutes.
Time frame: immediately after the preoperative informed consent discussion
Decisional Conflict Scale (DCS) Total Score
Total score of the Decisional Conflict Scale (16 items). Score range 0-100; higher scores indicate greater decisional conflict.
Time frame: immediately after the preoperative informed consent discussion
Vision-Related Quality of Life (Catquest-9SF, German Version)
Patient-reported visual function measured with the German version of the 9-item Catquest-9SF questionnaire, analyzed as Rasch-calibrated person score; lower scores indicate fewer difficulties with vision in daily life.
Time frame: immediately after the preoperative informed consent discussion
Usability of the PAULA App (System Usability Scale)
System Usability Scale (SUS), 10 items, assessed in the intervention group only. Score range 0-100; higher scores indicate better usability.
Time frame: immediately after the preoperative informed consent discussion
Workflow Efficiency as Rated by Clinical Staff
Individual assessments of clinical staff regarding the efficiency of the preoperative consent workflow.
Time frame: immediately after the preoperative informed consent discussion
Acceptance of the App and Difficulties Using the Tablet
Acceptance of the app and difficulties in handling the tablet, documented in written notes by clinical assistant staff.
Time frame: immediately after the preoperative informed consent discussion
Qualitative Participant Feedback
Oral qualitative feedback from participants on the informed consent process.
Time frame: immediately after the preoperative informed consent discussion
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2026 to primary completion in Oct 2026, 3 months.
Of 303 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 3 months is below that.
Counting every sponsor, half of 493 studies reached it within 17 months; a quarter within 9 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johannes Kepler University of Linz